Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 930

Cytochroma exits to Opko

Opko will pay $100m initially using its shares and the rest in performance fees.

Jan 14, 2013

Labcyte hears GE's money

GE Healthymagination, part of GE Ventures, led the D round as a new investor

Jan 14, 2013

Skilled Care Pharmacy gains Link-Age

Link-Age, a US group backed by several non profit assisted living centres, has invested in senior citizen focused pharmaceutical retailer Skilled Care Pharmacy in return for an equity stake.

Jan 14, 2013

Spinomix diagnoses Debiopharm investment

Founded in 2004 and located at the Swiss Federal Institute of Technology of Lausanne (EPFL), Lausanne, Spinomix helps with sample preparation of biological materials.

Jan 11, 2013

Ascension climbs to third fund

Three new limited partners will join CHV III, including Intermountain Healthcare of Salt Lake City, Utah, and Decatur Memorial Hospital of Decatur, Illionois.

Jan 10, 2013

Foundation Medicine taps into $13.5m

The company previously held a $42.5m first close on the round, including from Roche Venture Fund, WuXi Corporate Venture Fund, and Google Ventures.

Jan 10, 2013

Run3D finds its legs with Oxford

Bio-engineering company Run3D spins-out from the University of Oxford.

Jan 9, 2013

Stack and de Winter join GE

Risa Stack and Alex de Winter have joined corporate venturing healthcare investment programme GE Healthymagination.

Jan 8, 2013

Fidelity optimises Kyruus

US-based data start-up for hospitals and health systems Kyruus raises $11m in a series B round led by Lux Capital, which was joined by Fidelity Biosciences, Venrock and Highland Capital Partners.

Jan 7, 2013

Solstice receives $18m for RNA

US-based biotech startup Solstice Biologics, which has an exclusive licence with University of California, San Diego, receives $18m series A investment.

Jan 7, 2013
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here